Back to Results
First PageMeta Content
Medicine / Clinical medicine / Immunology / Immunosuppressants / RTT / Biotechnology / Autoimmune diseases / Arthritis / Certolizumab pegol / TNF inhibitor / UCB / Anakinra


UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol
Add to Reading List

Document Date: 2016-01-20 09:39:34


Open Document

File Size: 539,51 KB

Share Result on Facebook
UPDATE